The 2021/2022 US cough, cold and flu season is set to be one of the most volatile yet. Get the latest data-driven insights to allow you to plan and adapt with confidence during one of the key consumer health periods.

Watch back this insightful webinar now, see timecodes below:

Matthew Stewart provides a quick snapshot of where the global cough, cold and respiratory category sales performance stands from IQVIA Consumer Health audited data and some key insights into the performance drivers.

Doug Long gives the latest state of play of the COVID-19 pandemic in the US, including latest case trends, deaths and how the COVID-19 vaccine programme is performing, and a look at Flu vaccine rates.

Chip Schaible explores the potential impacts on the US 21/22 cough, cold and flu season as pandemic-driven cultural changes kick in. Utilising IQVIA Consumer Health FAN data, we dive into the early season trends, key indicators for the rest of the season and where the opportunities for your brands might lie.

Seasons will weaken generally, but adaption can equal success.

The panel answers audience questions.

You can download the presentation here, and visit our Concept and Strategy Development page to learn more about our solutions.

If you have an RFP in the area discussed during this webinar, please click the Green “CONTACT US” button floating on the bottom right of this page to discover the right solutions for you.